Omega (OMGA) - Forvard P/S multiplikatori
Omega Therapeutics (OMGA) uchun kelajakdagi P/S koeffitsiyenti dinamikasi likvidlik tanqisligi xatarlari va mRNA platformasi sinovlarining potentsial kechikishlariga bog'liqdir. Shu bilan birga, biznesni rivojlantirish makroiqtisodiyot va YaIMdan mustaqil qolmoqda, operatsion model esa tashqi ishlab chiqarish autsorsingiga tayanadi. 0.90 ning joriy qiymati investorga haddan tashqari yuqori baholangan kutishlarni yoki fundamental savdo o'sishini zudlik bilan aniqlash imkonini beruvchi metrika darajasini ifodalaydi.
Omega Therapeutics Corp (OMGA) kompaniyasi koʻrsatkichlari kesimi va tahlili
- bozor narxi va tahlilchilarning maqsadli narxlari:
- bozor kapitallashuvi ko'rsatkichlari:
- emitentning balans qiymati statistikasi:
- emitentning kredit yuki va likvidlik ko'rsatkichlari:
Umumiy qarzning xususiy kapitalga nisbati Omega Therapeutics|OMGA - Uzoq muddatli qarzning kapitalga nisbati|Qisqa muddatli qarzning o'z kapitaliga nisbati Omega Therapeutics|OMGA - Kompaniyaning yig'indi qarzdorligi|Balans kapitallashuviga qarzlar Omega Therapeutics Corp|OMGA - Uzoq muddatli qarz hajmi|Kompaniyaning qisqa muddatli qarzlari Omega Therapeutics|Tezkor likvidlik omegatherapeutics.com
- biznes foydasi va investitsiya koeffitsiyentlari ma'lumotlari:
OMGA - Sof moliyaviy natija|Kutilayotgan foyda Omega Therapeutics|OMGA - Kapitalizatsiyaning foydaga nisbati|Kelajakdagi narxning foydaga nisbati Omega|OMGA - Narx-foyda va o‘sish multiplikatori|EV/EBITDA multiplikatori Omega Therapeutics Corp|OMGA - Amortizatsiya ajratmalaridan oldingi operatsion foyda|Bir aksiya uchun sof foyda (EPS TTM) Omega Therapeutics|OMGA - Bir aksiya uchun sof foyda (EPS TTM)|Choraklik EPS foyda o'sishi omegatherapeutics.com|OMGA - Bu yil bir aksiya uchun foyda o'sishi|Keyingi yil uchun bir aksiya uchun sof foyda o'sishi prognozi Omega Therapeutics
- sotuv hajmi va tushum haqida ma'lumot:
Kompaniyaning umumiy tahlili:Omega Therapeutics, Inc. OMGA
Investorlar joriy daromadlar mavjud bo'lmagan holatlarda kelajakdagi pul oqimlari uchun haddan tashqari to'lov darajasini aniqlash uchun ushbu ko'rsatkichdan foydalanadilar. Kutilayotgan P/S koeffitsiyenti Omega Therapeutics (OMGA) kompaniyasining bozor qiymatini tushum prognozlariga solishtiradi, bu esa epigenetik dasturlash platformasining rivojlanishi va onkologik terapiya dori vositalarini joriy etish istiqbollari prizmasidan kapitalizatsiya salohiyatini baholash imkonini beradi.
Raqobatdosh kompaniyalar tahlili
Narxning prognoz qilingan daromadga nisbati Tempus AI, Inc. TEM|Sotuvga nisbatan forvard narx QGEN|Ionis Pharma - Forvard P/S multiplikatori|RGEN - Forvard P/S multiplikatori|Avidity Biosciences (RNA) - Narxning prognoz qilingan daromadga nisbati|Kelajakdagi narxning daromadga nisbati CRSP (crisprtx.com)|WGS (GeneDx) - Forvard P/S multiplikatori|Bozor kapitallashuvining kelajakdagi daromadga nisbati Ultragenyx Pharmaceutical Inc. RARE|Forvard narx/daromad multiplikatori BEAM (Beam Therapeutics Corp)|Forvard P/S multiplikatori Sarepta Corp (SRPT)|Twist Bioscience - Forvard narx/daromad multiplikatori|Narxning kutilayotgan daromadga nisbati TXG (10xgenomics.com)|Intellia Therapeutics, Inc. - Forvard P/S multiplikatori|Kapitalizatsiyaning kutilayotgan sotuvga nisbati Stoke Therapeutics Inc STOK|BLFS: Forvard P/S multiplikatori|Forvard narx/daromad multiplikatori Wave Pharma|Narxning prognoz qilingan daromadga nisbati Maze Therapeutics Inc|sionnatx.com (SION) - Kapitalizatsiyaning kutilayotgan sotuvga nisbati|Narxning prognoz qilingan daromadga nisbati Prime Medicine (PRME)|TSHA - Bozor kapitallashuvining kelajakdagi daromadga nisbati|Narxning prognoz qilingan daromadga nisbati uniQure Corp QURE|MGTX - Forvard narx/daromad multiplikatori|REGENXBIO Inc. - Forvard P/S multiplikatori|Prognoz narxning daromadga nisbati solidbio.com (SLDB)|OCGN: Forvard P/S multiplikatori|Pacific Biosciences of California, Inc. (PACB) - Forvard P/S multiplikatori|BNTC (Benitec) - Forvard P/S multiplikatori|Kapitalizatsiyaning prognoz qilingan daromadga nisbati DSGN (Design Corp)|Narxning prognoz qilingan daromadga nisbati Rocket Pharmaceuticals (RCKT)|4dmoleculartherapeutics.com - Kapitalizatsiyaning prognoz qilingan daromadga nisbati|Forvard P/S multiplikatori LXEO (Lexeo Therapeutics, Inc.)|Forvard P/S multiplikatori Korro Bio Inc. KRRO|EDIT - Narxning prognoz qilingan daromadga nisbati|Bozor kapitallashuvining kelajakdagi daromadga nisbati Silence Therapeutics Corp|proqr.com (PRQR) - Narxning prognoz qilingan daromadga nisbati|Forvard narx/daromad multiplikatori Codexis|SGMO (Sangamo Therapeutics, Inc.) - Forvard P/S multiplikatori|Bozor kapitallashuvining kelajakdagi daromadga nisbati Nautilus Biotechnology Inc NAUT|Forvard P/S multiplikatori MGX|Precision BioSciences Inc. (DTIL) - Prognoz narxning daromadga nisbati|Forvard P/S multiplikatori GBIO (Generation Bio)|Forvard P/S multiplikatori boundlessbio.com BOLD|XCUR: Forvard narx/daromad multiplikatori|Sotuvga nisbatan forvard narx IMNN (Imunon, Inc.)|PHIO (phiopharma.com) - Forvard narx/daromad multiplikatori|MBIO: Narxning kutilayotgan daromadga nisbati|RNAZ (TransCode Therapeutics Inc.) - Forvard P/S multiplikatori|BNGO: Sotuvga nisbatan forvard narx|Forvard P/S multiplikatori APDN|BLUE - Bozor kapitallashuvining kelajakdagi daromadga nisbati|Narxning prognoz qilingan daromadga nisbati ImmunoPrecise Antibodies Ltd. IPA|Sotuvga nisbatan forvard narx OMIC|Regulus Therapeutics - Forvard P/S multiplikatori|SYRS - Forvard P/S multiplikatori|Telesis Bio (TBIO) - Narxning prognoz qilingan daromadga nisbati|Kelajakdagi narxning daromadga nisbati TCON (TRACON Pharmaceuticals Inc.)|UBX (Unity Bio) - Forvard P/S multiplikatori
